CDH5 and neoplasm: In our analyses of structural changes of blood vessels in the tumor core region, we found that Thal dose-dependently increased α-SMA+ pericyte coverage, distribution of endothelial junctional molecules Claudin-5 and VE-cadherin on tumor vessels compared with control.